Illumina claims Element has "borrowed heavily" from the design of its sequencing systems and is seeking damages and an injunction in court.
Genome Sequences Provide New Details on Human Migration to the Americas
With genomic data for more than 1,500 members of diverse ethnic groups, researchers retraced population migrations and ancestry in northern Eurasia and South America.
Following a joint statement from the two countries on Monday, stocks of major life sciences tool and diagnostic companies rallied.
Pathos AI Raises $365M in Series D Financing to Advance AI Oncology Drug Development
The firm is developing an artificial intelligence engine that aims to accelerate the development and validation of biomarker-driven precision medicine drugs.
US Appeals Court Sends UC Berkeley, Broad Institute Back to the Mat in CRISPR-Cas9 Patent Dispute
Premium
It is unclear how the decision will eventually affect Editas Medicine and other companies relying on CRISPR-based technologies and products.
Bruker to Pay 10x Genomics $68M Under Global Settlement of Patent Disputes
The companies have inked global patent cross license agreements and will withdraw all ongoing lawsuits and administrative proceedings.
Qiagen Acquires NGS Analysis Software Firm Genoox for up to $80M
The acquisition is expected to generate $5 million in sales for Qiagen this year and have a neutral impact on the firm's EPS.
Quanterix Cuts 2025 Guidance Due to Tariffs, Academic Funding, as Q1 Revenues Fall 5 Percent
Premium
The company lowered its 2025 revenue guidance to between $120.0 million and $130.0 million, representing a year-over-year decline of 5 percent to 13 percent.